JFNCX
Price
$62.27
Change
+$0.40 (+0.65%)
Updated
Oct 8 closing price
Net Assets
4.49B
VHCIX
Price
$134.73
Change
+$0.39 (+0.29%)
Updated
Oct 8 closing price
Net Assets
17.67B
Interact to see
Advertisement

JFNCX vs VHCIX

Header iconJFNCX vs VHCIX Comparison
Open Charts JFNCX vs VHCIXBanner chart's image
Janus Henderson Global Life Sciences C
Price$62.27
Change+$0.40 (+0.65%)
VolumeN/A
Net Assets4.49B
Vanguard Health Care Index Admiral
Price$134.73
Change+$0.39 (+0.29%)
VolumeN/A
Net Assets17.67B
JFNCX vs VHCIX Comparison Chart in %
View a ticker or compare two or three
VS
JFNCX vs. VHCIX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNCX is a Buy and VHCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VHCIX has more cash in the bank: 17.7B vs. JFNCX (4.49B). VHCIX pays higher dividends than JFNCX: VHCIX (1.50) vs JFNCX (0.00). JFNCX was incepted earlier than VHCIX: JFNCX (16 years) vs VHCIX (22 years). JFNCX (1.76) is less costly to investors than VHCIX (0.09). JFNCX is a more actively managed with annual turnover of: 35.00 vs. VHCIX (4.00). JFNCX has a lower initial minimum investment than VHCIX: JFNCX (2500) vs VHCIX (100000). VHCIX annual gain was more profitable for investors over the last year : -3.13 vs. JFNCX (-8.04). VHCIX return over 5 years is better than : 27.43 vs. JFNCX (-0.63).
JFNCXVHCIXJFNCX / VHCIX
Total Expense Ratio1.760.091,956%
Annual Report Gross Expense Ratio1.760.091,956%
Fund Existence16 years22 years-
Gain YTD8.3356.054138%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets4.49B17.7B25%
Annual Yield % from dividends0.001.50-
Returns for 1 year-8.04-3.13257%
Returns for 3 years18.8019.0899%
Returns for 5 years-0.6327.43-2%
Returns for 10 years20.18113.4518%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEQYX20.230.06
+0.30%
Putnam Focused International Equity Y
AHSCX12.45N/A
N/A
Alger Health Sciences C
RRCOX65.34N/A
N/A
T. Rowe Price U.S. Equity Research R
VMIDX25.46N/A
N/A
VALIC Company I Mid Cap Index
MEFIX16.20N/A
N/A
ClearBridge Emerging Markets FI